跳至主要内容
临床试验/CTRI/2021/03/032236
CTRI/2021/03/032236尚未招募1 期

A double-blind randomised placebo-controlled study followed by an Open-label extension, comparative clinical study to evaluate the effect of PartySmart variants

The Himalaya Drug Company0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Males aged between 20-45 years, weighing more than 45 kgs
  • 2Subject who used to drink alcohol regularly (social drink not alcohol abuse) and is willing and able to comply with the alcohol consumption requirements and overnight stay as per the study requirements
  • 3.Subjects judged by the Investigator to be in general good health based on medical history.
  • 4.Subject understands the study procedures and signs the consent forms providing informed consent to participate in the study

排除标准

  • 1.Subject suspected for drug or alcohol abuse
  • 2.A medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation
  • 3.Subjective sleep duration of less than 3 hours in the night before the test
  • 4.Caffeine, nicotine or alcohol on the day (from midnight) of the test
  • 5.Use of psycho-active drugs during the past 30 days or any treatment that might interfere with the evaluation of the test drug
  • 6.Any drug known to interact with benzodiazepines and related drugs, e.g. antiepileptics, antihistaminics, muscle relaxant drugs, antihypertensive drugs, drugs inhibiting cytochrome P450
  • 7.Any clinically significant disorder that might interfere with his/her participation in this study and the evaluation of the efficacy or safety of the test drug (e.g. renal insufficiency, hepatic or metabolic dysfunction, cardiovascular disease, neurological and or psychiatric disorder etc.)
  • 8.Known hypersensitivity to any of the ingredients of the study drugs
  • 9.Participation in any other clinical trial within the past 30 days

研究者

相似试验

已完成
2 期
A double-blind randomised placebo controlled study to evaluate the effects of different doses of testosterone from a Testosterone Metered-Dose Transdermal Spray (MDTS) on sexual function in premenopausal women with low libidoow libido in post menopausal women suffering from low serum testosteroneLow libido in post menopausal women suffering from low serum testosteroneReproductive Health and Childbirth - Menstruation and menopause
ACTRN12605000481673FemPharm Pty Ltd and/or Acrux DDS Pty Ltd200
进行中(未招募)
2 期
A double-blind randomized placebo-controlled study of Desvenlafaxine for managing vasomotor symptoms in breast cancer survivorsVasomotor symptoms
TCTR20210326006Khon Kaen University60
已完成
不适用
A randomised double-blind placebo-controlled study of energy, protein and micronutrients supplementation of elderly patients in active rehabilitation settingsutritional status in the elderlyNutritional, Metabolic, EndocrineNutritional status
ISRCTN01133608The Health Foundation (UK)445
已完成
不适用
A randomised double-blind placebo-controlled study to investigate the possible role of Opiate Morphine (MST) in the treatment of chronic cough.
ISRCTN18474014Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)30
已完成
3 期
A randomised double-blind placebo-controlled study to evaluate the effect ofcurcumin on BDNF levels in otherwise healthy adults.Brain-Derived Neurotrophic Factor in healthy adultsNeurological - Studies of the normal brain and nervous systemAlternative and Complementary Medicine - Other alternative and complementary medicine
ACTRN12621000104853RDC Global Pty Ltd69